월경전불쾌장애의 약물치료 3상 임상 연구 메타분석

PHARMACOTHERAPY FOR PREMENSTRUAL DYSPHORIC DISORDER: A META-ANALYSIS OF PHASE 3 TRIALS

초록

Premenstrual dysphoric disorder (PMDD) is a common condition that temporarily, but repetitively affects patient’s global function. Patients and physicians alike are often uncertain whether prescription medication for PMDD is suffi ciently effective. The primary objective of this analysis is signal detection in effi cacy of pharmacological treatments in PMDD. Secondary objective is to review which symptoms are likely to respond to which medications. The review included otherwise healthy women with clinician confi rmed diagnosis of PMDD who participated in phase 3 clinical trials for the treatment of PMDD. Twelve pair-wise comparisons of drug and placebo for 2,420 patients with PMDD were performed. Oral contraceptives and selective serotonin receptor inhibitor were effective in alleviating symptoms of PMDD compared to placebo. Both Intermittent and continuous administration were more effective than placebo. This meta-analysis provides a signal that pharmacological treatment of PMDD is effective

키워드

Premenstrual syndromeDrug therapyMeta-analysisClinical trialphase 3월경전불쾌장애 약물치료메타분석3상 임상 연구
제목
월경전불쾌장애의 약물치료 3상 임상 연구 메타분석
제목 (타언어)
PHARMACOTHERAPY FOR PREMENSTRUAL DYSPHORIC DISORDER: A META-ANALYSIS OF PHASE 3 TRIALS
저자
염선경유민지박나윤김성민이경욱박현태신정호허준용김선행김탁
발행일
2012
저널명
Obstetrics & Gynecology Science
55
03
페이지
143 ~ 147